Psychiatrists and neuroscientists are trying to use biological markers in the brain for depression and other psychiatric disorders to sharpen diagnoses and find more precise treatments.
Why it matters: Mental health disorders affect an estimated 1 in 4 adults in the U.S. each year. More than half don't receive treatment, and for those that take medication, finding the most effective one can be a trial-and-error process.
The Food and Drug Administration issued an emergency use authorization for an AstraZeneca COVID-19 antibody drug for people with compromised immune systems.
Why it matters: The drug, Evusheld, is the first antibody therapy authorized in the U.S. to prevent coronavirus symptoms before virus exposure.
